vTv Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 0.009 million compared to USD 0.009 million a year ago. Net loss was USD 4.75 million compared to USD 9.48 million a year ago.

Basic loss per share from continuing operations was USD 0.06 compared to USD 0.11 a year ago.